FDA approves Amgen's Repatha, 2nd in new class of breakthrough cholesterol drugs
August 27, 2015 at 17:18 PM EDT
Amgen Inc. has won approval for the second medicine in a new class of biotech drugs that reduce artery-clogging cholesterol more than older statin drugs that have been used for decades.